A sneak peek of 2023

A sneak peek of 2023

With the holiday season fast approaching, 2022 will soon be in our rearview mirror. The American College of Surgeons (ACS) cancer programs are already moving forward with exciting plans for the products, services, and projects we will provide to accredited cancer components and programs in 2023. Here’s a preview of what you can expect in the next year .

The CoC standards manual will incorporate updates to the pathology reporting accreditation requirements: the Cancer Commission standards manual, Optimal Resources for Cancer Care (2020 Standards), will be updated with substantive changes to Standard 5.1: College of American Pathologists (CAP) Synoptic Report. The on-site review of pathology reports for CAP compliance during the site visit will be eliminated and replaced with the requirement to conduct an internal audit of pathology reports to assess whether the report includes all required elements and is in good standing. synoptic format. In addition, Standard 3.2: Evaluation and Treatment Services will be revised to require anatomical pathology accreditation by a recognized organization. The revised standards, along with the implementation schedule, will be published in early 2023.

New STORE 2023 data items as of January 1: The Standards Manual for Oncology Registry Entry (STORE v2023), effective for cases diagnosed on January 1, 2023, was published on October 7, 2022. The manual can be found on the Request for Registration webpage. data from the National Cancer Database (NCDB) located at Registry Manuals (https://www.facs.org/quality-programs/cancer-programs/national-cancer-database/ncdb-call-for-data/). See the chapter “2023 STORE Changes Summary” on page 29 for a description of the changes to STORE this year. Additional communications and details will follow.

Be part of a National Quality Improvement Project 2023: ACS Cancer Programs is pleased to announce two new quality improvement initiatives launching in early 2023:

  • Beyond ASK is a quality improvement project that will help any cancer program learn skills and implement local process improvement strategies so that more cancer patients are referred to effective anti-smoking treatment.
  • The Breaking Barriers project is designed to help programs understand and address patient barriers to cancer care. The project will use local data to drive program change and share innovations with a national audience.

More information about these initiatives, including important details and timelines, will be forthcoming.

NAPBC to incorporate feedback, provide resources, and educate on new accreditation standards: the National Accreditation Program for Breast Centers (NAPBC) will pilot its recently released revised accreditation standards. Based on feedback from the program and the results of the pilot site visits, an updated version of Optimal Breast Care Resources (2024 Standards) it will be published in the fall of 2023 and will be ready for implementation on January 1, 2024. Education and resources to help implement the standards will be published throughout 2023.

New cancer surgery protocols to be released in 2022 and 2023: the Cancer Surgery Standards Program (CSSP) will publish new cancer surgery protocols for Kindle and print-on-demand on the Amazon website. These protocols provide guidance on collecting essential data and key aspects of cancer surgery through the operative report and can serve as a useful educational tool for surgeons in training. Protocols for melanoma and breast and colon cancers will be published in late 2022. Protocols for thyroid, pancreatic, lung, gastric and adrenal cancers will be published in 2023. Publication details will be published via Cancer Programs News When available.

2023 webinars to address informational and educational content: ACS Cancer Programs educational leaders plan to launch a series of webinars in 2023 that will address informational and educational topics of interest to a wide range of Cancer Programs constituents. Educational webinars will address content beyond the topics covered in the in-person conference and offer relevant continuing education credits. Clock Cancer Programs News for more information on webinar content and schedule.

New AJCC staging protocols posted online, more to come in 2023: Three new ninth version American Joint Committee on Cancer (AJCC) Protocols on Anal, Appendicular, and Brain Cancer have now been published for Kindle and are print-on-demand at the Amazon website. Each protocol provides comprehensive staging information, including site-specific staging rules, diagnostic and pathologic staging tables, and survival curves demonstrating prognosis and supporting evidence for each stage group. The standardized format and clear illustrations and tables make the protocols a quick reference to help with staging. Six new neuroendocrine, pulmonary, and vulvar protocols are expected to be published in 2023.

Cancer Research Program to Post Survival Services Survey: the ACS Cancer Research Program (CRP) will publish a survey in 2023 to learn the prevalence and types of services offered by survivorship programs in CoC-accredited cancer programs. Details on how to participate will be shared via Cancer Programs News in the coming months.

CSSP Hosts a Webinar on Technical Standards for Pancreatic Cancer Surgery: The CSSP will host a webinar in early 2023 on Technical Standards for Pancreatic Cancer Surgery (Pancreaticoduodenectomy). An expert panel will discuss evidence-based operating standards for performing pancreaticoduodenectomy as described in the Operative standards for cancer surgery Handbook. The information will be available through Cancer Programs News.

Programs can apply for CoC Pediatric Secondary Accreditation in mid-2023: The application for accreditation of the CoC’s new pediatric cancer secondary program will be launched within Quality Portal (QPort) during the third quarter of 2023. At that time, programs will be able to request a site visit in 2024.

Quality Measures 2023: What You Need to Know: Quality measures have played a vital role in evaluating program performance in accordance with best cancer practices. These measures are continually reviewed to ensure they are up to date. With that in mind, beginning in January 2023, measurements of breast hormones, post-mastectomy radiation, needle biopsy, and lung surgery will be withdrawn from the market. Cancer rapid notification system (RCRS). Clinical updates to existing breast chemotherapy and radiation measures, as well as pulmonary chemotherapy, rectal radiation and chemotherapy, and gastric node measures will be announced in January 2023. Cancer show news. The revised measures will be available in the second quarter of 2023.

Changes to the Integrity Report in 2023: the National Cancer Database is finalizing plans to transition the default and comprehensive Overuse Report, currently housed in QPort and updated annually, to a new home on the RCRS platform. The new report will be populated in a more real-time manner and with newer data, while also being slightly simplified to focus on fewer, higher-value data elements. More details about the timing of this launch in 2023 will be communicated.

Leave a Comment